Division of Interventional Radiology, The Mount Sinai Medical Center, New York, NY.
Division of Vascular Surgery, The Mount Sinai Medical Center, New York, NY.
J Vasc Surg. 2020 Oct;72(4):1237-1246.e1. doi: 10.1016/j.jvs.2020.02.016. Epub 2020 Apr 8.
Transradial access (TRA) has traditionally been favored for coronary interventions. Tools with up to 200 cm length now allow operators to treat infrainguinal peripheral arterial disease (PAD) using TRA. This study aims to assess the safety and feasibility of TRA infrainguinal interventions.
Patients with infrainguinal PAD who underwent intervention via TRA from July 2013 through June 2019 were retrospectively reviewed. Exclusion criteria included Barbeau D waveform, a radial artery diameter of greater than 2 mm, radial artery occlusion, Raynaud syndrome, or peripheral vasculitis. Procedural success (adequate inline flow to the foot), TRA alone failure (crossover or use of an additional access site), clinical success (defined as improvement in ankle brachial index, clinical symptoms, or wound healing) and adverse events were recorded from procedure notes and follow-up visits.
Thirty-six procedures were attempted using TRA in 32 patients (mean age, 65.8 years; range, 29-86; 22 male, 14 female) with mean height of 65.8 inches (range, 59.0-72.0 inches) and a body mass index of 28.7 (range, 19.1-43.9). Preprocedure Rutherford classification (II/III/IV/V/VI) was 8/15/2/7/4, respectively. The left radial artery was used for 35 of 36 procedures (97.2%). Treated vessels included the common femoral (n = 4), superficial femoral (n = 25), deep femoral (n = 1), popliteal (n = 10), tibioperoneal trunk (n = 2), tibial (n = 4), and plantar (n = 1) arteries. Interventions included angioplasty (n = 32, 100%), atherectomy (n = 8, 25%), and stenting (n = 13, 41%). Procedural success was 100%, the TRA alone failure rate was 11.1%, and clinical success was 89.3%. The median follow-up was 286.5 days (range, 0-919 days). Adverse events included radial artery pseudoaneurysm (n = 1), access site hematoma/bleeding (n = 3), radial artery occlusion (n = 1), groin hematoma (n = 1), popliteal artery dissection treated with stenting (n = 2), and a small superficial femoral artery perforation (n = 1) treated with prolonged balloon tamponade. No patients experienced signs of cerebrovascular events or distal embolism.
TRA is a useful option for treating patients with PAD; however, several limitations still exist.
经桡动脉入路(TRA)传统上一直是冠状动脉介入治疗的首选方法。现在,长度可达 200 厘米的工具可使操作者使用 TRA 治疗下肢外周动脉疾病(PAD)。本研究旨在评估 TRA 下肢介入治疗的安全性和可行性。
回顾性分析 2013 年 7 月至 2019 年 6 月期间采用 TRA 进行下肢 PAD 介入治疗的患者。排除标准包括 Barbeau D 波型、桡动脉直径大于 2 毫米、桡动脉闭塞、雷诺综合征或周围血管炎。从手术记录和随访中记录手术成功率(足部有足够的直达血流)、仅 TRA 失败(交叉或使用其他入路)、临床成功率(定义为踝肱指数、临床症状或伤口愈合改善)和不良事件。
32 例患者(平均年龄 65.8 岁,范围 29-86 岁;男性 22 例,女性 14 例)共进行了 36 次 TRA 治疗,平均身高为 65.8 英寸(范围 59.0-72.0 英寸),体重指数为 28.7(范围 19.1-43.9)。术前 Rutherford 分级(II/III/IV/V/VI)分别为 8/15/2/7/4。36 次手术中有 35 次(97.2%)使用左桡动脉。治疗的血管包括股总动脉(n=4)、股浅动脉(n=25)、股深动脉(n=1)、腘动脉(n=10)、胫腓动脉干(n=2)、胫前动脉(n=4)和足底动脉(n=1)。介入治疗包括血管成形术(n=32,100%)、动脉切除术(n=8,25%)和支架置入术(n=13,41%)。手术成功率为 100%,仅 TRA 失败率为 11.1%,临床成功率为 89.3%。中位随访时间为 286.5 天(0-919 天)。不良事件包括桡动脉假性动脉瘤(n=1)、穿刺部位血肿/出血(n=3)、桡动脉闭塞(n=1)、腹股沟血肿(n=1)、股浅动脉夹层行支架治疗(n=2)和小股浅动脉穿孔(n=1)行长时间球囊填塞治疗。无患者出现脑血管事件或远端栓塞迹象。
TRA 是治疗 PAD 患者的一种有用方法;然而,仍存在一些局限性。